Prospective Study of Active Pain Management in Lung Cancer Outpatients (APM) — APM  

Lung Cancer Clinical Trial

Official title: A Randomized Prospective Controlled Study of Active Pain Management in Lung Cancer Outpatients (APM)

Status Completed

Clinical Trial Summary

This study is:

• A single-center, randomized, prospective controlled trial.

• To prove superiority of active pain management group compared to control group by the percent of pain intensity difference of outpatients with lung cancer pain.

• 204 patients will be recruited.

Clinical Trial Description

• The recruited patients in both group will be provided the education about pain-killer, and received medicines including opioids according to their numeric rating scale (NRS)

• Active management group will be provided additional telephone counseling and dosage modification by specialized nurse for cancer pain.

• The percent of pain intensity difference (%PID)

• PID = (NRS of visit 1 - NRS of visit 3)/NRS of visit 1 ;

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

• NCT number: NCT01310387
• Study type: Interventional
• Source: Chonnam National University Hospital
• Status: Completed
• Phase: Phase 3
• Start date: January 2011
• Completion date: June 2012